1-201365220-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM1PM2PP3_ModeratePP5_Moderate
The NM_001276345.2(TNNT2):c.382G>A(p.Glu128Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001276345.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
The Glu118Lys variant in TNNT2 has not been reported in the literature, but has been identified by our laboratory in 1 infant with congenital DCM and was not id entified in either parent, thus likely occurring de novo. This variant has also not been identified in large and broad European American and African American po pulations by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EV S), which increases the likelihood that the variant is pathogenic. However, we c annot exclude that it may be common in other populations. Glutamic acid (Glu) at position 118 is highly conserved in mammals and across evolutionarily distant s pecies, though dolphin has another amino acid at this position. The change to Ly sine (Lys) was predicted to be pathogenic using a computational tool clinically validated by our laboratory. This tool's pathogenic prediction is estimated to b e correct 94% of the time (Jordan 2011). In summary, the de novo occurrence and computational predictions support that this variant is likely pathogenic, though additional studies are needed to fully assess its clinical significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at